Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

Guillain-Barré syndrome (GBS) is an autoimmune disease that usually happens after a viral illness, vaccination, or infection ...

Guillain-Barré Syndrome is rare but can happen to anyone. Recognizing the first symptoms—tingling, weakness, difficulty walking—can make all the difference. Shweta’s journey from paralysis ...

Nashik has reported its first case of Guillain-Barre Syndrome in a 60-year-old man. The condition, which causes the immune system to attack peripheral nerves, has been reported in 250 cases in ...

The report's release coincides with Rare Disease Day, a global initiative to raise awareness and generate support for everyone with a rare disease, as well as the latest edition of the Foundation ...

Guillain-Barre Syndrome (pronounced Gee-luhn-Baa Syndrome ... genetic markers that may influence susceptibility and disease severity. Since GBS is often triggered by infections, early and accurate ...

We present a case of Guillain-Barré syndrome in a child who received hepatitis A vaccine 5 days before onset of the clinical symptoms. In our patient, the association of Guillain-Barré syndrome ...